DarioHealth Reports Third Quarter 2024 Financial and Operating Results
DarioHealth Corp. (DRIO)
NASDAQ:AMEX Investor Relations:
dariohealth.com/our-story
Company Research
Source: PR Newswire
Demonstrated strong improvements in financial performance and business momentum.Q3 revenue of $7.42 million increased 18.7% over Q2 2024 and 111% compared to Q3 2023, driven by expansion of B2B2C revenues.Q3 operating loss decreased sequentially by 25.7% to $12 million on a GAAP basis and by 33.3% to $7.1 million on a non-GAAP basis over Q2 2024.Executed synergies from the Dario-Twill merger, expected to reduce operating expenses by approximately 38% by Q1 2025 (compared to Q1 2024) and contributing to an expected 49% reduction in operating losses by Q1 2025 and 59% in non-GAAP operating losses.Significant wins include: 10 B2B2C clients, including a national Medicare advantage health plan, a regional Medicaid health plan, and a global leading pharma company.Made significant progress in transforming the pharma/medical device channel into a platform-based recurring revenue model by securing two new deals, including one with one of the top six global pharma companies.Dario remains on tra
Show less
Read more
Impact Snapshot
Event Time:
DRIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRIO alerts
High impacting DarioHealth Corp. news events
Weekly update
A roundup of the hottest topics
DRIO
News
- DarioHealth Corp (DRIO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User EngagementPR Newswire
- Dario Signs New Regional Health Plan, Expanding Reach in Medicaid PopulationPR Newswire
- DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7thPR Newswire
- Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition PlatformPR Newswire
DRIO
Earnings
- 11/7/24 - Beat
DRIO
Sec Filings
- 11/7/24 - Form 10-Q
- 10/29/24 - Form SC
- 10/24/24 - Form DEF
- DRIO's page on the SEC website